Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
ColoCare Study - Colorectal Cancer Cohort
for
Colorectal Cancer
Location: Tampa FL, Knoxville TN, St Louis MO, Salt Lake City UT,
Sponsor: University of Utah
Sex: All
Age: 18 - 70+
Code: NCT02328677
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Tampa FL, Orlando FL, Charleston SC, Atlanta GA,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase 3, Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
for
NSCLC
Location: Tampa FL, Charleston SC, Houston TX, Fairfax VA,
Sponsor: Lung Cancer Mutation Consortium
Sex: All
Age: 0+
Code: NCT04712877
Recruiting
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
for
Hepatocellular Carcinoma, Biliary Tract Cancer
Location: Tampa FL, Miami FL, Knoxville TN, Germantown TN,
Sponsor: Replimune Inc.
Sex: All
Age: 18+
Code: NCT05733598
Phase 2, Recruiting
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
for
Breast Cancer, Triple Negative Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06435351
Early Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Tampa FL, Charlotte NC, Houston TX, Cincinnati OH,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Tampa FL, Clermont FL, Fort Lauderdale FL, Daphne AL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
for
Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04741997
Early Phase 1, Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Tampa FL, Houston TX, Columbus OH, St Louis MO,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
for
Myeloma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06947083
Phase 2, Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
for
High Grade Sarcoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05301283
Phase 2, Recruiting
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Tampa FL, Cincinnati OH, San Antonio TX,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18+
Code: NCT06234397
Phase 1, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Orlando FL, Jacksonville FL, Augusta GA, Atlanta GA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Tampa FL, Nashville TN, Denver CO, Houston TX,
Sponsor: Nested Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06326411
Phase 1, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Tampa FL, Orlando FL, Atlanta GA, Charlotte NC,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
for
Advanced Basal Cell Carcinoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05651828
Early Phase 1, Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Tampa FL, Chapel Hill NC, Lexington KY, Morgantown WV,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Tampa FL, Weston FL, Thomasville GA, Savannah GA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Tampa FL, Birmingham AL, Nashville TN, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Tampa FL, Sarasota FL, Nashville TN, Houston TX,